ID

14816

Descrizione

A Phase 1 Study Evaluating AMG 232 in Advanced Solid Tumors or Multiple Myeloma; ODM derived from: https://clinicaltrials.gov/show/NCT01723020

collegamento

https://clinicaltrials.gov/show/NCT01723020

Keywords

  1. 29/04/16 29/04/16 -
Caricato su

29 aprile 2016

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY 4.0

Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Commenti del gruppo di articoli per :

Commenti dell'articolo per :

Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

Eligibility Advanced Malignancy NCT01723020

Eligibility Advanced Malignancy NCT01723020

Inclusion Criteria
Descrizione

Inclusion Criteria

Alias
UMLS CUI
C1512693
men or women > 18 years old
Descrizione

age

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0001779
pathologically documented, definitively diagnosed, advanced solid tumor that is refractory to standard treatment, or which no standard therapy is available, or the subject refuses standard therapy or multiple myeloma
Descrizione

solid tumor

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0280100
willing to undergo pre-dose core needle tumor biopsies or bone marrow aspirate for subjects with multiple myeloma.
Descrizione

needle tumor biopsy or bone marrow aspirate

Tipo di dati

boolean

Alias
UMLS CUI [1]
C1318309
UMLS CUI [2]
C1271729
ability to take oral medications and willing to record daily adherance to investigational product
Descrizione

oral medication

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0175795
adequate hematological, renal, hepatic, and coagulation laboratory assessments
Descrizione

adequate hematological, renal, hepatic, and coagulation laboratory assessments

Tipo di dati

boolean

Alias
UMLS CUI [1]
C1254358
Exclusion Criteria
Descrizione

Exclusion Criteria

Alias
UMLS CUI
C0680251
active brain metastases
Descrizione

brain metastases

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0220650
for solid tumor-history or presence of hematological malignancies unless curatively treated with no evidence of disease for greater than or equal to 5 years
Descrizione

hematological malignancies

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0376545
active infection requiring intravenous (iv) antibiotics
Descrizione

active infection requiring intravenous (iv) antibiotics

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0199779
UMLS CUI [1,2]
C0009450
anti-tumor therapy
Descrizione

cancer treatment

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0920425
therapeutic or palliative radiation therapy within 30 days of starting treatment
Descrizione

radiation

Tipo di dati

boolean

Alias
UMLS CUI [1]
C1522449
UMLS CUI [2]
C3898008
currently enrolled in another investigational device or drug study
Descrizione

currently enrolled in another investigational device or drug study

Tipo di dati

boolean

Alias
UMLS CUI [1]
C2348568

Similar models

Eligibility Advanced Malignancy NCT01723020

Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
C1512693 (UMLS CUI)
age
Item
men or women > 18 years old
boolean
C0001779 (UMLS CUI [1])
solid tumor
Item
pathologically documented, definitively diagnosed, advanced solid tumor that is refractory to standard treatment, or which no standard therapy is available, or the subject refuses standard therapy or multiple myeloma
boolean
C0280100 (UMLS CUI [1])
needle tumor biopsy or bone marrow aspirate
Item
willing to undergo pre-dose core needle tumor biopsies or bone marrow aspirate for subjects with multiple myeloma.
boolean
C1318309 (UMLS CUI [1])
C1271729 (UMLS CUI [2])
oral medication
Item
ability to take oral medications and willing to record daily adherance to investigational product
boolean
C0175795 (UMLS CUI [1])
adequate hematological, renal, hepatic, and coagulation laboratory assessments
Item
adequate hematological, renal, hepatic, and coagulation laboratory assessments
boolean
C1254358 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
brain metastases
Item
active brain metastases
boolean
C0220650 (UMLS CUI [1])
hematological malignancies
Item
for solid tumor-history or presence of hematological malignancies unless curatively treated with no evidence of disease for greater than or equal to 5 years
boolean
C0376545 (UMLS CUI [1])
active infection requiring intravenous (iv) antibiotics
Item
active infection requiring intravenous (iv) antibiotics
boolean
C0199779 (UMLS CUI [1,1])
C0009450 (UMLS CUI [1,2])
cancer treatment
Item
anti-tumor therapy
boolean
C0920425 (UMLS CUI [1])
radiation
Item
therapeutic or palliative radiation therapy within 30 days of starting treatment
boolean
C1522449 (UMLS CUI [1])
C3898008 (UMLS CUI [2])
currently enrolled in another investigational device or drug study
Item
currently enrolled in another investigational device or drug study
boolean
C2348568 (UMLS CUI [1])

Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

I campi contrassegnati da * sono obbligatori.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial